These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 17836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tyrosinase activity and abundance in Cloudman melanoma cells.
    Halaban R, Pomerantz SH, Marshall S, Lerner AB.
    Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
    [Abstract] [Full Text] [Related]

  • 3. MSH stimulates adenylate cyclase and tyrosinase in cultivated melanoma cells in the presence of cytochalasin B.
    DiPasquale A, McGuire J.
    Exp Cell Res; 1976 Oct 15; 102(2):264-8. PubMed ID: 185075
    [No Abstract] [Full Text] [Related]

  • 4. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.
    Slominski A, Moellmann G, Kuklinska E.
    J Cell Sci; 1989 Apr 15; 92 ( Pt 4)():551-9. PubMed ID: 2557357
    [Abstract] [Full Text] [Related]

  • 5. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
    Fuller BB, Lunsford JB, Iman DS.
    J Biol Chem; 1987 Mar 25; 262(9):4024-33. PubMed ID: 3031058
    [Abstract] [Full Text] [Related]

  • 6. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
    Pawelek J, Sansone M, Koch N, Christie G, Halaban R, Hendee J, Lerner AB, Varga JM.
    Proc Natl Acad Sci U S A; 1975 Mar 25; 72(3):951-5. PubMed ID: 165495
    [Abstract] [Full Text] [Related]

  • 7. [Chemico-clinical aspects of tyrosinase (author's transl)].
    Pavel S, Matous B.
    Cesk Dermatol; 1976 Dec 25; 51(6):413-9. PubMed ID: 827337
    [No Abstract] [Full Text] [Related]

  • 8. PHrmonal specificity of the melanotropin-sensitive adenylate cyclase of mouse melanoma and effect of cyclic AMP on the tyrosinase activity of mouse melanoma cells, in vitro.
    Lee TH, Lee MS.
    Biochim Biophys Acta; 1976 Aug 24; 444(1):181-91. PubMed ID: 8131
    [Abstract] [Full Text] [Related]

  • 9. The effects of pro-opiomelanocortin peptides on cyclic AMP and tyrosinase in melanoma cells.
    Farah JM, Bishop JF, Nguyen HQ, O'Donohue TL.
    Peptides; 1986 Aug 24; 7(3):437-41. PubMed ID: 3022251
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
    Abdel-Malek ZA, Swope VB, Trinkle LS, Nordlund JJ.
    Exp Cell Res; 1989 Jan 24; 180(1):198-208. PubMed ID: 2462505
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM, Abdel Malek ZA, Kreutzfeld KL, Hadley ME, Wilkes BC, Hruby VJ, Castrucci AM.
    Mol Cell Endocrinol; 1985 Jul 24; 41(2-3):171-7. PubMed ID: 3926559
    [Abstract] [Full Text] [Related]

  • 12. Insulin-mediated inhibition of tyrosinase activity and protein synthesis in melanoma cell cultures.
    Fuller BB, Ehlers SE.
    Endocrinology; 1984 Jan 24; 114(1):222-6. PubMed ID: 6317345
    [Abstract] [Full Text] [Related]

  • 13. Response of mouse melanoma cells to melanocyte stimulating hormone.
    Wong G, Pawelek J, Sansone M, Morowitz J.
    Nature; 1974 Mar 22; 248(446):351-4. PubMed ID: 4362188
    [No Abstract] [Full Text] [Related]

  • 14. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
    Lee TH, Lee MS.
    Acta Endocrinol (Copenh); 1977 Mar 22; 84(3):663-72. PubMed ID: 402759
    [Abstract] [Full Text] [Related]

  • 15. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
    Hoganson GE, Ledwitz-Rigby F, Davidson RL, Fuller BB.
    Somat Cell Mol Genet; 1989 May 22; 15(3):255-63. PubMed ID: 2543086
    [Abstract] [Full Text] [Related]

  • 16. Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones.
    Wong G, Pawelek J.
    Nat New Biol; 1973 Feb 14; 241(111):213-5. PubMed ID: 4349438
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of tyrosinase activity and protein synthesis in melanoma cells by calcium ionophore A23187.
    Fuller BB.
    Pigment Cell Res; 1987 Feb 14; 1(3):176-80. PubMed ID: 2854256
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
    Thody AJ, Oliver I, Sherbet GV.
    Eur J Cancer Clin Oncol; 1988 Dec 14; 24(12):1879-84. PubMed ID: 2851444
    [Abstract] [Full Text] [Related]

  • 19. Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone.
    Jiménez M, Kameyama K, Maloy WL, Tomita Y, Hearing VJ.
    Proc Natl Acad Sci U S A; 1988 Jun 14; 85(11):3830-4. PubMed ID: 3131764
    [Abstract] [Full Text] [Related]

  • 20. Effects of alpha-MSH on melanogenesis and tyrosinase of B-16 melanoma.
    Lee TH, Lee MS, Lu MY.
    Endocrinology; 1972 Nov 14; 91(5):1180-8. PubMed ID: 4627367
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.